Quetiapine-induced hypothyroidism

Journal of Psychiatry and Neuroscience

Volumn 30, Issue 1, 2005, Pages 57-

  Ramaswamy, Sriram ^a   Siddiqui, Zakaria ^a   Saharan, Sahdev ^a   Gabel, Teri L ^a   Bhatia, Subhash C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; LEVOTHYROXINE; LITHIUM; QUETIAPINE; VALPROIC ACID; ZIPRASIDONE; DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ADULT; AUTOIMMUNITY; CASE REPORT; DRUG INDUCED DISEASE; FEMALE; HUMAN; HYPOTHYROIDISM; LETTER; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; CHEMICALLY INDUCED DISORDER;

ADULT; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; FEMALE; HUMANS; HYPOTHYROIDISM; PSYCHOTIC DISORDERS;

EID: 14144255526     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. SEROQUEL (quetiapine fumarate) [product monograph]. Rev 1/01. Wilmington (DE): AstraZeneca Pharmaceuticals; 2001.
2. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, at al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30(2):239-45.
3. Lazarus JH, John R, Bennie EH, Chalmers RJ, Crockett G. Lithium therapy and thyroid function: a long-term study. Psychol Med 1981;11(1):85-92.
4. Leroy MC, Villeneuve A, Lajeunesse C. Lithium and antithyroid antibodies. Am J Psychiatry 1988;145(4):534.
5. Johnston AM, Eagles JM. Lithium-associated clinical hypothyroidism. Prevalence and risk factors. Br J Psychiatry 1999;175:336-9.
6. Feret BM, Caley CF. Possible hypothyroidism associated with quetiapine. Ann Pharmacother 2000;34(4):483-6.